|
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 2, 2011) - Pacgen Biopharmaceuticals Corporation (the "Company" or "Pacgen") (TSX VENTURE:PGA) announced today that it has reached an agreement in principle with CurieMed Corporation ("CurieMed") with respect to a non-brokered private placement (the "Financing") of $300,000 of common shares ("Common Shares"). Completion of the Financing is subject to satisfactory completion of certain conditions, including the approvals of the Company's shareholders and the TSX Venture Exchange. |
